Gowling WLG is pleased to announce Dr. Christopher Bown as the new national leader of the firm's Patent Group in Canada, succeeding John Harris.

With more than 20 years of experience in patent law and a PhD in Medical Sciences, Christopher has built a strong reputation for managing complex IP portfolios and guiding clients representing diverse industries, such as life sciences, biotechnology, and mining. His leadership will focus on advancing the group's holistic approach to portfolio management and optimization, ensuring that intellectual property becomes a catalyst for innovation and a strategic asset in driving business growth.

"Today's trailblazing businesses understand that success isn't just about protecting their inventions—it's about realizing the full potential of their intellectual property and seamlessly aligning their IP strategy with their broader business objectives," said Christopher. "I'm looking forward to working alongside our team to help our clients transform their IP into a sustainable competitive advantage."

"Regardless of their sector or market, our clients are under growing pressure to maximize the value of their intellectual property and ensure it contributes directly to their overarching strategic priorities," said Shelagh Carnegie, Co-head of Gowling WLG's Global Intellectual Property Group. "Christopher's proven leadership and his exceptional track record will enhance our ability to deliver tailored solutions that protect client innovations and drive meaningful results."

About Gowling WLG's Patent Group

Our Canadian IP team is home to award-winning patent professionals. Whether you're looking to file, commercialize or enforce your patents and industrial designs, our renowned patent group can advise on the right protection strategy. They regularly coordinate and direct the prosecution of patent applications worldwide. We frequently represent leading national and global companies before the Canadian Intellectual Property Office (CIPO). Learn more about our patent team.